Stockreport

Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF in drug delivery platforms, today announced that it has entered into definitive agreements for the purchase and sale of 1,558,443 shares of common stock (or common stock [Read more]